Examine a dual-targeting immune-cell therapy approach designed to dismantle a brain tumor's protective immune microenvironment and tumor cells.
Key Takeaways
- New research demonstrates that glioblastoma is not merely a collection of cancer cells
- Glioblastoma is one of the most aggressive and difficult-to-treat cancers, with devastatingly poor survival
- Glioblastoma is extremely hard to treat for many reasons